Optimal tumor targeting by antibodies: Development of a mathematical model
- 1 April 1991
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 19 (2) , 227-260
- https://doi.org/10.1007/bf01073870
Abstract
A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The model is compartmental and nonlinear, incorporating saturable binding. Published parameter values have been used in the model, and the resulting stiff differential equations have been solved using FACSIMILE, a computer package that can simulate very stiff differential systems. Results show that successful tumor targeting depends on an optimal combination of antibody dose, affinity, and molecular size. The model has allowed an assessment to be made of the complicated and interrelated dynamic relationships that these factors have on tumor targeting. It has also offered an explanation for previously unsatisfactory results from tumor targeting with labeled antibodies. The structural identifiability of the model parameters is also analyzed and it is shown that, with the prior knowledge of some parameters which is likely in practice, the remaining model parameters are uniquely identifiable.Keywords
This publication has 31 references indexed in Scilit:
- Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convectionPublished by Elsevier ,2004
- Global identifiability of the parameters of nonlinear systems with specified inputs: A comparison of methodsMathematical Biosciences, 1990
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Radioimmunotherapy of cancer: clinical studies and limiting factorsCancer Treatment Reviews, 1987
- Antibody protein dose and radioimmunodetection of gw‐39 human colon tumor xenograftsInternational Journal of Cancer, 1987
- Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumorsSeminars in Nuclear Medicine, 1985
- The deterministic identifiability of nonlinear pharmacokinetic modelsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- First order dissociation rates between a subpopulation of high affinity rabbit anti-fluorescyl IgG antibody and homologous ligandMolecular Immunology, 1980
- System identifiability based on the power series expansion of the solutionMathematical Biosciences, 1978